Stay updated with breaking news from Ioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Following its $10 million Series A financing in July 2023, Camena Bioscience has appointed Dr Nicola Thompson as Chair of its Board of Directors as part of plans for commercial expansion of its DNA synthesis platform, gSynth™. Click to read more...
In New York, we are one step away from ensuring access to biomarker testing for millions of residents who stand to benefit. The final step is for Governor Hochul to
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that H.E Dr. Jean Kaseya, Director General of Africa CDC visited SK bioscience headquarters on November 3 to discuss collaboration with the Partnerships for African Vaccine Manufacturing (PAVM).
The University of Georgia has introduced a Ph.D. program in regenerative bioscience. The formalized doctoral program, set to launch in spring 2024 is the first to be offered in the
Vancouver, Canada, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Renaissance BioScience Corp (www.renaissancebioscience.com), a leader in bioengineering for the global agriculture, animal health, human medicine, and food sector, is pleased to announce its recent patent award from the China patent office. This patent grant, representing the first for its innovative yeast-based platform technology for the production and delivery of RNA bioactive molecules, enhances Renaissance's robust IP portfolio, which inc